Enfusion (ENFN) News Today $10.85 +0.05 (+0.45%) Closing price 04/17/2025Extended Trading$10.85 0.00 (0.00%) As of 04/17/2025 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Financial Contrast: Enfusion (NYSE:ENFN) and NetObjects (OTCMKTS:NETO)April 29, 2025 | americanbankingnews.comClearwater Analytics reinstated with an Overweight at JPMorganApril 26, 2025 | markets.businessinsider.comNekton Capital Ltd. Takes Position in Enfusion, Inc. (NYSE:ENFN)Nekton Capital Ltd. bought a new position in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 43,611 shares of the company's stock, valued at apprApril 24, 2025 | marketbeat.comClearwater Analytics: 3 Acquisitions That Make This A Strong BuyApril 24, 2025 | seekingalpha.comJPMorgan Chase & Co. Acquires 95,310 Shares of Enfusion, Inc. (NYSE:ENFN)JPMorgan Chase & Co. increased its position in Enfusion, Inc. (NYSE:ENFN - Free Report) by 45.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 303,332 shares of the company's stock after purchasing an additionApril 23, 2025 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) Short Interest UpdateEnfusion, Inc. (NYSE:ENFN - Get Free Report) was the recipient of a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 1,300,000 shares, an increase of 28.7% from the March 15th total of 1,010,000 shares. Approximately 3.3% of the shares of the company are short sold. Based on an average daily volume of 1,210,000 shares, the short-interest ratio is currently 1.1 days.April 21, 2025 | marketbeat.comClearwater Analytics Finalizes Acquisition of EnfusionApril 21, 2025 | businesswire.comEnfusion, Inc. (NYSE:ENFN) Shares Sold by ExodusPoint Capital Management LPExodusPoint Capital Management LP lowered its holdings in Enfusion, Inc. (NYSE:ENFN - Free Report) by 74.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 31,388 shares of the company's stock after selling 90,779April 15, 2025 | marketbeat.comVanguard Group Inc. Has $34.42 Million Holdings in Enfusion, Inc. (NYSE:ENFN)Vanguard Group Inc. trimmed its position in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) by 16.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,341,561 shares of the company's stock after selling 676,April 15, 2025 | marketbeat.comEVR Research LP Makes New $4.12 Million Investment in Enfusion, Inc. (NYSE:ENFN)EVR Research LP purchased a new stake in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 400,000 shares of the company's stock, valueApril 14, 2025 | marketbeat.comTrexquant Investment LP Takes Position in Enfusion, Inc. (NYSE:ENFN)Trexquant Investment LP acquired a new position in Enfusion, Inc. (NYSE:ENFN - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 58,681 shares of the company's stock, valued at approximately $604,000. OthApril 14, 2025 | marketbeat.comWellington Management Group LLP Increases Position in Enfusion, Inc. (NYSE:ENFN)Wellington Management Group LLP lifted its position in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) by 6.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,035,996 shares of the company's stApril 12, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Takes $2.36 Million Position in Enfusion, Inc. (NYSE:ENFN)Arrowstreet Capital Limited Partnership acquired a new stake in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 228,898 shares of the company's stock, valued at approximatelyApril 12, 2025 | marketbeat.comClearwater Analytics and Enfusion Announce Election Deadline for Enfusion Shareholders to Elect Form of Merger ConsiderationApril 2, 2025 | businesswire.comENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFNApril 2, 2025 | businesswire.comScalar Gauge Management LLC Sells 428,513 Shares of Enfusion, Inc. (NYSE:ENFN)Scalar Gauge Management LLC decreased its holdings in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) by 94.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 25,000 shares of the company's stock after selling 428,513 shares during the period. EnfusiApril 1, 2025 | marketbeat.comFox Run Management L.L.C. Invests $265,000 in Enfusion, Inc. (NYSE:ENFN)Fox Run Management L.L.C. bought a new stake in Enfusion, Inc. (NYSE:ENFN - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 25,736 shares of the company's stock, valued at approximately $265,000. Other institutional iMarch 29, 2025 | marketbeat.comRoyce & Associates LP Increases Stock Position in Enfusion, Inc. (NYSE:ENFN)Royce & Associates LP lifted its stake in Enfusion, Inc. (NYSE:ENFN - Free Report) by 84.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 184,078 shares of the company's stock after acquiring an additional 84,363 shMarch 22, 2025 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) General Counsel Sells $19,289.10 in StockEnfusion, Inc. (NYSE:ENFN - Get Free Report) General Counsel Matthew Campobasso sold 1,695 shares of Enfusion stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $11.38, for a total transaction of $19,289.10. Following the completion of the sale, the general counsel now owns 70,946 shares in the company, valued at approximately $807,365.48. This trade represents a 2.33 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.March 8, 2025 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) Insider Bronwen Bastone Sells 3,126 SharesEnfusion, Inc. (NYSE:ENFN - Get Free Report) insider Bronwen Bastone sold 3,126 shares of the business's stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $11.38, for a total transaction of $35,573.88. Following the sale, the insider now directly owns 221,875 shares in the company, valued at $2,524,937.50. The trade was a 1.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.March 8, 2025 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) CFO Sells $52,860.10 in StockEnfusion, Inc. (NYSE:ENFN - Get Free Report) CFO Bradley Herring sold 4,645 shares of Enfusion stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $11.38, for a total value of $52,860.10. Following the completion of the sale, the chief financial officer now owns 324,689 shares of the company's stock, valued at $3,694,960.82. This trade represents a 1.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.March 8, 2025 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) CEO Oleg Movchan Sells 11,452 SharesEnfusion, Inc. (NYSE:ENFN - Get Free Report) CEO Oleg Movchan sold 11,452 shares of Enfusion stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $11.39, for a total transaction of $130,438.28. Following the transaction, the chief executive officer now owns 631,847 shares in the company, valued at approximately $7,196,737.33. This trade represents a 1.78 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.March 8, 2025 | marketbeat.comNeal Pawar Sells 14,560 Shares of Enfusion, Inc. (NYSE:ENFN) StockEnfusion, Inc. (NYSE:ENFN - Get Free Report) COO Neal Pawar sold 14,560 shares of the stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $11.38, for a total transaction of $165,692.80. Following the completion of the sale, the chief operating officer now directly owns 1,217,067 shares in the company, valued at approximately $13,850,222.46. The trade was a 1.18 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.March 8, 2025 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) General Counsel Sells $19,289.10 in StockMarch 8, 2025 | insidertrades.comMatthew Campobasso Sells 1,081 Shares of Enfusion, Inc. (NYSE:ENFN) StockEnfusion, Inc. (NYSE:ENFN - Get Free Report) General Counsel Matthew Campobasso sold 1,081 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $11.48, for a total value of $12,409.88. Following the completion of the sale, the general counsel now directly owns 72,641 shares in the company, valued at $833,918.68. This represents a 1.47 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.March 6, 2025 | marketbeat.comBradley Herring Sells 1,533 Shares of Enfusion, Inc. (NYSE:ENFN) StockEnfusion, Inc. (NYSE:ENFN - Get Free Report) CFO Bradley Herring sold 1,533 shares of Enfusion stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $11.48, for a total transaction of $17,598.84. Following the completion of the transaction, the chief financial officer now owns 329,334 shares of the company's stock, valued at $3,780,754.32. This trade represents a 0.46 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.March 6, 2025 | marketbeat.comInsider Selling: Enfusion, Inc. (NYSE:ENFN) Insider Sells 2,064 Shares of StockEnfusion, Inc. (NYSE:ENFN - Get Free Report) insider Bronwen Bastone sold 2,064 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $11.48, for a total transaction of $23,694.72. Following the completion of the transaction, the insider now directly owns 225,001 shares in the company, valued at approximately $2,583,011.48. The trade was a 0.91 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.March 6, 2025 | marketbeat.comNeal Pawar Sells 2,769 Shares of Enfusion, Inc. (NYSE:ENFN) StockEnfusion, Inc. (NYSE:ENFN - Get Free Report) COO Neal Pawar sold 2,769 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $11.48, for a total value of $31,788.12. Following the completion of the sale, the chief operating officer now directly owns 1,231,627 shares of the company's stock, valued at approximately $14,139,077.96. This trade represents a 0.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.March 6, 2025 | marketbeat.comInsider Selling: Enfusion, Inc. (NYSE:ENFN) CEO Sells 2,790 Shares of StockEnfusion, Inc. (NYSE:ENFN - Get Free Report) CEO Oleg Movchan sold 2,790 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $11.48, for a total transaction of $32,029.20. Following the completion of the sale, the chief executive officer now owns 643,299 shares of the company's stock, valued at $7,385,072.52. This represents a 0.43 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.March 6, 2025 | marketbeat.comMatthew Campobasso Sells 1,081 Shares of Enfusion, Inc. (NYSE:ENFN) StockMarch 6, 2025 | insidertrades.comEnfusion, Inc.: Enfusion Announces Fourth Quarter and Full Year 2024 ResultsMarch 4, 2025 | finanznachrichten.deEnfusion (ENFN) to Release Earnings on TuesdayEnfusion (NYSE:ENFN) will be releasing earnings before the market opens on Tuesday, March 11, Financial Modeling Prep reports.March 4, 2025 | marketbeat.comEnfusion (NYSE:ENFN) Announces Quarterly Earnings Results, Misses Expectations By $0.02 EPSEnfusion (NYSE:ENFN - Get Free Report) issued its quarterly earnings data on Monday. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.03 by ($0.02). Enfusion had a return on equity of 6.67% and a net margin of 1.70%.March 3, 2025 | marketbeat.comEnfusion Announces Fourth Quarter and Full Year 2024 ResultsMarch 3, 2025 | businesswire.comClearwater Analytics and Enfusion Announce Expiration of Hart-Scott-Rodino Act Waiting Period For Proposed Acquisition of EnfusionFebruary 26, 2025 | businesswire.comImpax Asset Management Group plc Raises Position in Enfusion, Inc. (NYSE:ENFN)Impax Asset Management Group plc increased its holdings in Enfusion, Inc. (NYSE:ENFN - Free Report) by 31.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 890,000 shares of the company's stock after puFebruary 25, 2025 | marketbeat.comENFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Enfusion, Inc. ...February 25, 2025 | gurufocus.comENFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Enfusion, Inc. Is Fair to ShareholdersFebruary 25, 2025 | businesswire.comEnfusion, Inc. (NYSE:ENFN) Stake Boosted by New York State Common Retirement FundNew York State Common Retirement Fund boosted its stake in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) by 23.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,926,968 shares of the company's stock afterFebruary 23, 2025 | marketbeat.comEnfusion (NYSE:ENFN) Hits New 1-Year High - Here's What HappenedEnfusion (NYSE:ENFN) Sets New 1-Year High - Should You Buy?February 21, 2025 | marketbeat.comClearwater Analytics' Enfusion Infusion Offers Compelling Value Proposition, Analyst Upgrades StockFebruary 20, 2025 | benzinga.comEnfusion, Inc. (NYSE:ENFN) Sees Significant Increase in Short InterestEnfusion, Inc. (NYSE:ENFN - Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 1,010,000 shares, a growth of 41.9% from the January 15th total of 711,700 shares. Based on an average trading volume of 797,400 shares, the days-to-cover ratio is currently 1.3 days. Approximately 2.4% of the shares of the stock are sold short.February 15, 2025 | marketbeat.comEnfusion, Inc. (ENFN): Among The Small–Cap Stocks Insiders Are Selling RecentlyFebruary 15, 2025 | msn.comClearwater Analytics Holdings Inc. (CWAN) Among Hot Tech Stocks to Buy Right NowFebruary 6, 2025 | msn.comEnfusion, Inc. (NYSE:ENFN) Given Average Rating of "Hold" by BrokeragesShares of Enfusion, Inc. (NYSE:ENFN - Get Free Report) have been assigned an average recommendation of "Hold" from the six brokerages that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and tFebruary 6, 2025 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) Shares Sold by SG Americas Securities LLCSG Americas Securities LLC trimmed its position in Enfusion, Inc. (NYSE:ENFN - Free Report) by 72.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,929 shares of the company's stockFebruary 6, 2025 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) Sees Large Growth in Short InterestEnfusion, Inc. (NYSE:ENFN - Get Free Report) was the target of a large growth in short interest in January. As of January 15th, there was short interest totalling 711,700 shares, a growth of 27.9% from the December 31st total of 556,500 shares. Based on an average daily volume of 695,500 shares, the short-interest ratio is currently 1.0 days. Approximately 1.5% of the shares of the stock are short sold.February 1, 2025 | marketbeat.comEnfusion, Inc. (NYSE:ENFN) Shares Bought by JPMorgan Chase & Co.JPMorgan Chase & Co. grew its stake in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) by 612.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 208,022 shares of the company's stock aJanuary 23, 2025 | marketbeat.comWilliam Blair downgrades Enfusion (ENFN) to a HoldJanuary 18, 2025 | markets.businessinsider.comEnfusion (NYSE:ENFN) Sees Unusually-High Trading Volume - Here's WhyEnfusion (NYSE:ENFN) Sees Unusually-High Trading Volume - Should You Buy?January 16, 2025 | marketbeat.com Get Enfusion News Delivered to You Automatically Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter. Email Address ENFN Media Mentions By Week ENFN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENFN News Sentiment▼0.000.77▲Average Computer and Technology News Sentiment ENFN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENFN Articles This Week▼13▲ENFN Articles Average Week Get Enfusion News Delivered to You Automatically Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OS News QTWO News CLBT News VRNS News BILL News GRND News GDS News BOX News INTA News FRSH News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ENFN) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enfusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enfusion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ENFN Stock Free ENFN Stock Alerts